Multiple primary melanoma following administration of levodopa.
D000284:Administration, Oral; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010300:Parkinson Disease / Q000188:drug therapy; D012878:Skin Neoplasms / Q000473:pathology
D004295:Dihydroxyphenylalanine